BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19485299)

  • 1. Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration.
    Shah SP; Hubschman JP; Gonzales CR; Schwartz SD
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):308-15. PubMed ID: 19485299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.
    González-López JJ; McGowan G; Chapman E; Yorston D
    Eye (Lond); 2016 Jul; 30(7):929-35. PubMed ID: 27055681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
    Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H; Bardak Y; Erçalık Y; Erdem B; Arslan G; Timlioglu S
    Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND SURGICAL OUTCOMES OF TISSUE PLASMINOGEN ACTIVATOR-ASSISTED VITRECTOMY FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Hirashima T; Moriya T; Bun T; Utsumi T; Hirose M; Oh H
    Retina; 2015 Oct; 35(10):1969-78. PubMed ID: 26079475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ; Ho-Yen G; Clarke B; Barbara R; Lash S; Papathomas T; Antonakis S; Gupta B
    Eur J Ophthalmol; 2021 Mar; 31(2):643-648. PubMed ID: 31813290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Cho HJ; Koh KM; Kim HS; Lee TG; Kim CG; Kim JW
    Am J Ophthalmol; 2013 Sep; 156(3):524-531.e1. PubMed ID: 23769197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
    Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT; Sjaarda RN
    Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E; Steel DH; Liazos E; McHugh D; Jackson TL
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
    Cho HJ; Koh KM; Kim JH; Kim HS; Han JI; Lew YJ; Lee TG; Kim JW
    Retina; 2015 Feb; 35(2):205-12. PubMed ID: 25105310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage.
    Lewis H
    Am J Ophthalmol; 1994 Nov; 118(5):559-68. PubMed ID: 7977569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F; Klatt C; Roider J; Hillenkamp J
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
    Dewilde E; Delaere L; Vaninbroukx I; Van Calster J; Stalmans P
    Acta Ophthalmol; 2014 Sep; 92(6):e497-8. PubMed ID: 24943231
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.
    van Zeeburg EJ; Cereda MG; van Meurs JC
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):733-40. PubMed ID: 22865261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.